首页> 外文期刊>Molecular cancer research: MCR >The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
【24h】

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

机译:实体瘤中的EphA2受体和ephrinA1配体:功能和治疗靶向。

获取原文
获取原文并翻译 | 示例
           

摘要

The Eph receptor tyrosine kinases and ephrin ligands have been studied extensively for their roles in developmental processes. In recent years, Eph receptors and ephrins have been found to be integral players in cancer formation and progression. Among these are EphA2 and ephrinA1, which are involved in the development and maintenance of many different types of solid tumors. The function of EphA2 and ephrinA1 in tumorigenesis and tumor progression is complex and seems to be dependent on cell type and microenvironment. These variables affect the expression of the EphA2 and ephrinA1 proteins, the pathways through which they induce signaling, and the functional consequences of that signaling on the behavior of tumor cells and tumor-associated cells. This review will specifically focus on the roles that EphA2 and ephrinA1 play in the different cell types that contribute to the malignancy of solid tumors, with emphasis on the opportunities for therapeutic targeting.
机译:Eph受体酪氨酸激酶和ephrin配体已被广泛研究其在发育过程中的作用。近年来,已发现Eph受体和ephrins在癌症形成和发展中起着不可或缺的作用。其中有EphA2和ephrinA1,它们参与许多不同类型的实体瘤的发展和维持。 EphA2和ephrinA1在肿瘤发生和肿瘤进展中的功能是复杂的,似乎取决于细胞类型和微环境。这些变量影响EphA2和ephrinA1蛋白的表达,它们诱导信号传导的途径以及该信号传导对肿瘤细胞和肿瘤相关细胞行为的功能后果。这篇综述将特别关注EphA2和ephrinA1在不同类型的细胞中所扮演的角色,这些细胞会导致实体瘤的恶性肿瘤,并着重介绍治疗靶向的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号